Media Newsroom of

Parnell

Parnell (OTC:PARNF) is a fully integrated, veterinary pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions.

Parnell Pharmaceuticals Holdings Ltd Announces Business Update

Parnell Pharmaceuticals Holdings Ltd Announces Business Update

Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF) today announced: ongoing 2019 revenue growth of 9% to September 30 compared with the first 9 months of 2018; commencement of technical work to establish the first of three new contract manufactured products; and…

Parnell Appoints Tony G Hartnell AM to Board of Directors

Parnell Appoints Tony G Hartnell AM to Board of Directors

Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, today announced the appointment of Anthony G Hartnell AM to its Board of Directors. “We are indeed fortunate…

Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended June 30, 2017

Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended June 30, 2017

Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, today announced an update on business results including strong revenue growth of 25% to $10.3 million, substantial improvement…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or Signup using Email

Already have an account ? Login

Reset Password

Already have an account ? Login